LINCO – 600
Advanced Antibiotic for Serious Bacterial Infections
LINCO-600 is a premium-quality Linezolid 600 mg Tablet from Citric Labs, formulated to treat severe bacterial infections caused by susceptible Gram-positive bacteria. Linezolid belongs to the oxazolidinone class of antibiotics and is commonly prescribed for complicated skin infections, pneumonia, and infections caused by resistant bacteria such as MRSA and VRE under medical supervision. It works by inhibiting bacterial protein synthesis, effectively stopping the growth and spread of infection.
Composition
- Linezolid 600 mg
Key Benefits
- Effective against serious Gram-positive bacterial infections
- Helps treat community-acquired and hospital-acquired pneumonia
- Useful in complicated skin and soft tissue infections
- Active against resistant organisms including MRSA and VRE (as prescribed)
- High-quality formulation with consistent therapeutic efficacy
- Manufactured under strict quality control standards
- Ideal product for PCD Pharma Franchise and pharmaceutical marketing
Product Description
LINCO-600 contains Linezolid 600 mg, an advanced antibiotic used for the treatment of serious bacterial infections including pneumonia and complicated skin infections. Manufactured by Citric Labs, it is a trusted choice for healthcare providers and an excellent product for PCD Pharma Franchise and pharmaceutical distribution across India.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
